Inventor · disambiguated record
Michael Downes
Also filed as: DOWNES MICHAEL · DOWNES MICHAEL R
50 granted patents·36 pending applications·267 citations·filing 2000–2024
98Inventor score
Files withSALK INST FOR BIOLOGICAL STUDI69MITOBRIDGE INC8SALK INST BIOLOGICAL STUDIES3EVANS ROLAND M2DOWNES MICHAEL R1
Top patents by PatentIndex Score
86 records- 0198US8999929B2Fibroblast growth factor 1 protein fragments and methods of useSALK INST FOR BIOLOGICAL STUDI·Filed 2014·Granted Apr 7, 2015·57 cites·26 claims
- 0295US9072708B2Methods for treating metabolic disorders using FGFSALK INST FOR BIOLOGICAL STUDI·Filed 2014·Granted Jul 7, 2015·19 cites·44 claims
- 0395US8906854B2Methods for treating metabolic disorders using FGFSALK INST FOR BIOLOGICAL STUDI·Filed 2014·Granted Dec 9, 2014·20 cites·40 claims
- 0494US10399958B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2016·Granted Sep 3, 2019·7 cites·20 claims
- 0594US10077268B2FXR agonists and methods for making and usingSALK INST FOR BIOLOGICAL STUDI·Filed 2016·Granted Sep 18, 2018·9 cites·2 claims
- 0693US10035819B2PPAR agonists and methods of use thereofSALK INST BIOLOGICAL STUDIES·Filed 2017·Granted Jul 31, 2018·13 cites·18 claims
- 0792US11685901B2Compositions and methods for organoid generation and disease modelingSALK INST FOR BIOLOGICAL STUDI·Filed 2022·Granted Jun 27, 2023·1 cites·19 claims
- 0892US11376264B2Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatmentSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Granted Jul 5, 2022·3 cites·18 claims
- 0992US10301268B2Analogs of fexaramine and methods of making and usingSALK INST FOR BIOLOGICAL STUDI·Filed 2016·Granted May 28, 2019·4 cites·31 claims
- 1092US9938234B2PPAR agonistsSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Apr 10, 2018·13 cites·10 claims
- 1192US9446097B2Methods for treating metabolic disorders using FGFSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Sep 20, 2016·8 cites·21 claims
- 1291US10479775B1PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Nov 19, 2019·7 cites·20 claims
- 1390US9808508B2Methods for treating metabolic disorders using FGFSALK INST FOR BIOLOGICAL STUDI·Filed 2016·Granted Nov 7, 2017·5 cites·25 claims
- 1489US9546379B2Compositions and methods for treating type 1 and type 2 diabetes and related disordersSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Jan 17, 2017·7 cites·4 claims
- 1588US6673587B1Histone deacetylase, and uses thereforSALK INST FOR BIOLOGICAL STUDI·Filed 2000·Granted Jan 6, 2004·30 cites·25 claims
- 1687US11578052B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2021·Granted Feb 14, 2023·1 cites·16 claims
- 1786US10920199B2Reprogramming progenitor compositions and methods of use thereforeSALK INST FOR BIOLOGICAL STUDI·Filed 2016·Granted Feb 16, 2021·4 cites·14 claims
- 1886US10912800B2Compositions and methods for treating type 1 and type 2 diabetes and related disordersSALK INST FOR BIOLOGICAL STUDI·Filed 2016·Granted Feb 9, 2021·5 cites·19 claims
- 1986US9925241B2Mutated fibroblast growth factor (FGF) 1 and methods of useSALK INST FOR BIOLOGICAL STUDI·Filed 2014·Granted Mar 27, 2018·6 cites·15 claims
- 2085US8212006B2Structure of the farnesoid X receptor ligand binding domain and methods of use thereforDOWNES MICHAEL R·Filed 2010·Granted Jul 3, 2012·10 cites·8 claims
- 2184US10906885B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Feb 2, 2021·1 cites·18 claims
- 2284US10293027B2Methods for treating metabolic disorders using FGFSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted May 21, 2019·2 cites·20 claims
- 2384US10159711B2Methods for treating metabolic disorders using FGFSALK INST FOR BIOLOGICAL STUDI·Filed 2016·Granted Dec 25, 2018·2 cites·21 claims
- 2484US2024417383A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2024·Application pending·0 cites
- 2582US9925243B2Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of useSALK INST FOR BIOLOGICAL STUDI·Filed 2016·Granted Mar 27, 2018·5 cites·32 claims
- 2682US2023373948A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2023·Application pending·0 cites
- 2781US8318708B2Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosisEVANS ROLAND M·Filed 2010·Granted Nov 27, 2012·6 cites·12 claims
- 2880US10398759B2Methods for treating metabolic disorders using FGFSALK INST FOR BIOLOGICAL STUDI·Filed 2017·Granted Sep 3, 2019·1 cites·46 claims
- 2980US7671085B2Non-steroidal farnesoid X receptor modulators and methods for the use thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2003·Granted Mar 2, 2010·8 cites·18 claims
- 3080US2024101962A1Compositions and methods for organoid generation and disease modelingSALK INST FOR BIOLOGICAL STUDI·Filed 2023·Application pending·0 cites
- 3179US9872866B2Vitamin D receptor/SMAD genomic circuit gates fibrotic responseSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Jan 23, 2018·2 cites·5 claims
- 3277US10695404B2Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogsSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Jun 30, 2020·1 cites·28 claims
- 3375US12253527B2Compositions and methods for treating age-related diabetes and related disordersSALK INST FOR BIOLOGICAL STUDI·Filed 2022·Granted Mar 18, 2025·0 cites·16 claims
- 3475US11428697B2Compositions and methods for treating age-related diabetes and related disordersSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Granted Aug 30, 2022·0 cites·8 claims
- 3574US10550071B2PPAR agonistsSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Feb 4, 2020·1 cites·18 claims
- 3673US12213999B2Compositions and methods for treating type 1 and type 2 diabetes and related disordersSALK INST FOR BIOLOGICAL STUDI·Filed 2021·Granted Feb 4, 2025·0 cites·20 claims
- 3773US11440889B2Analogs of fexaramine and methods of making and usingSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Granted Sep 13, 2022·0 cites·20 claims
- 3873US10539572B2Compositions and methods for treating age-related diabetes and related disordersSALK INST FOR BIOLOGICAL STUDI·Filed 2016·Granted Jan 21, 2020·1 cites·15 claims
- 3973US9192601B2Methods for enhancing muscle performance and toneEVANS ROLAND M·Filed 2008·Granted Nov 24, 2015·2 cites·14 claims
- 4073US7647217B2Structure of the farnesoid X receptor ligand binding domain and methods of use thereforSALK INST FOR BIOLOGICAL STUDI·Filed 2003·Granted Jan 12, 2010·1 cites·3 claims
- 4172US9895381B2Vitamin D receptor agonists to treat diseases involving CXCL12 activitySALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Feb 20, 2018·2 cites·8 claims
- 4271US10815203B2Analogs of fexaramine and methods of making and usingSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Granted Oct 27, 2020·0 cites·20 claims
- 4371US2019358296A1Methods for treating metabolic disorders using fgfSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Application pending·0 cites
- 4470US11130779B2PPAR agonists and methods of use thereofSALK INST BIOLOGICAL STUDIES·Filed 2019·Granted Sep 28, 2021·0 cites·20 claims
- 4568US2020040051A1Fibroblast growth factor (fgf) 1 with mutation in the heparin binding domain and methods of use to reduce blood glucoseSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Application pending·0 cites
- 4667US8962546B2Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses thereforNARKAR VIHANG A·Filed 2012·Granted Feb 24, 2015·2 cites·18 claims
- 4767US2023097335A1Fibroblast growth factor 1 (fgf1) mutant proteins that selectively activate fgfr1b to reduce blood glucoseSALK INST FOR BIOLOGICAL STUDI·Filed 2022·Application pending·0 cites
- 4866US11420934B2PPAR agonistsSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Granted Aug 23, 2022·0 cites·15 claims
- 4966US10450277B2Analogs of fexaramine and methods of making and usingSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Oct 22, 2019·0 cites·18 claims
- 5065US11760977B2Compositions and methods for organoid generation and disease modelingSALK INST FOR BIOLOGICAL STUDI·Filed 2017·Granted Sep 19, 2023·0 cites·16 claims
Showing the top 50 of 86 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →